Ganglioside GM2

Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ganglioside GM2?

Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Ganglioside GM2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ganglioside GM2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ganglioside GM2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ganglioside GM2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ganglioside GM2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ganglioside GM2?

Disease model

Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Ganglioside GM2

Download all related citations
Per page 10 20 50 100 | Total 558
Authors Title Published Journal PubMed Link
pmid:14766311
pmid:11495348
pmid:
pmid:8120069
pmid:19559406
pmid:18473163
Woods AS et al. Gangliosides and ceramides change in a mouse model of blast induced traumatic brain injury. 2013 ACS Chem Neurosci pmid:23590251
Ho CW et al. Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors. 2010 ACS Chem. Biol. pmid:20187655
Obi T et al. IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides. 1992 Acta Neurol. Scand. pmid:1384262
Sindern E et al. Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy. 1991 Acta Neurol. Scand. pmid:1887763
Martin DR et al. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis. 2005 Acta Neuropathol. pmid:16200419
Gieselmann V What can cell biology tell us about heterogeneity in lysosomal storage diseases? 2005 Acta Paediatr Suppl pmid:15895717
Kroll RA et al. White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities. AJNR Am J Neuroradiol pmid:7677013
Raghavan SS et al. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures. 1985 Am. J. Hum. Genet. pmid:2934978
Navon R et al. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A. 1985 Am. J. Hum. Genet. pmid:3156493
Conzelmann E et al. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. 1983 Am. J. Hum. Genet. pmid:6614006
Inui K et al. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. 1983 Am. J. Hum. Genet. pmid:6224417
Li YT et al. Differentiation of two variants of type-AB GM2-gangliosidosis using chromogenic substrates. 1983 Am. J. Hum. Genet. pmid:6222647
Johnson WG et al. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies. 1980 Am. J. Hum. Genet. pmid:6772023
O'Brien JS and Geiger B Normal adult with absent HEX A: immunoreactive HEX A is present. 1979 Am. J. Hum. Genet. pmid:507054
O'Brien JS et al. Characterization of unusual hexosaminidase A (HEX A) deficient human mutants. 1978 Am. J. Hum. Genet. pmid:747188
Xie B et al. A Cys138-to-Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidosis. 1992 Am. J. Hum. Genet. pmid:1570834
dos Santos MR et al. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal. 1991 Am. J. Hum. Genet. pmid:1832817
Navon R et al. Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect. 1990 Am. J. Hum. Genet. pmid:2278539
Pierce KR et al. Animal model of human disease: GM2 gangliosidosis. 1976 Am. J. Pathol. pmid:817606
Gori AH et al. Mediation of attachment of Burkholderia pseudomallei to human pharyngeal epithelial cells by the asialoganglioside GM1-GM2 receptor complex. 1999 Am. J. Trop. Med. Hyg. pmid:10497993
Dufresne M et al. Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry. 2017 Anal Bioanal Chem pmid:27873002
Schwarz A et al. Isolation of gangliosides by cloud-point extraction with a nonionic detergent. 1997 Anal. Biochem. pmid:9417780
Fuller M et al. Liquid chromatography/electrospray ionisation-tandem mass spectrometry quantification of GM2 gangliosides in human peripheral cells and plasma. 2014 Anal. Biochem. pmid:24769373
Nakamura M et al. Radioimmune assay of sialyltransferase and N-acetylgalactosaminyltransferase activities using specific antibodies on a 96-well filtration plate of a multiscreen assay system. 1991 Anal. Biochem. pmid:1789418
Kushi Y et al. Direct analysis of glycolipids on thin-layer plates by matrix-assisted secondary ion mass spectrometry: application for glycolipid storage disorders. 1988 Anal. Biochem. pmid:3149874
Kim CS et al. Functional interaction analysis of GM1-related carbohydrates and Vibrio cholerae toxins using carbohydrate microarray. 2012 Anal. Chem. pmid:22770420
Chen Y et al. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease. 2008 Anal. Chem. pmid:18314967
Boardman AK et al. Interface of an array of five capillaries with an array of one-nanoliter wells for high-resolution electrophoretic analysis as an approach to high-throughput chemical cytometry. 2008 Anal. Chem. pmid:18717573
Sato K et al. Chemical synthesis of biologically active monoglycosylated GM2-activator protein analogue using N-sulfanylethylanilide peptide. 2013 Angew. Chem. Int. Ed. Engl. pmid:23765733
Stubbs KA et al. A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells. 2009 Angew. Chem. Int. Ed. Engl. pmid:19130519
Caudie C et al. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Ann. Biol. Clin. (Paris) pmid:10518060
Burg J et al. Mapping of the gene coding for the human GM2 activator protein to chromosome 5. 1985 Ann. Hum. Genet. pmid:3865618
Swallow DM et al. Regional localization of the gene coding for the GM2 activator protein (GM2A) to chromosome 5q32-33 and confirmation of the assignment of GM2AP to chromosome 3. 1993 Ann. Hum. Genet. pmid:8257088
Tifft CJ and Proia RL The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse. 1997 Ann. Med. pmid:9562524
Nakamura K et al. Anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection. 1998 Ann. N. Y. Acad. Sci. pmid:9668386
Walkley SU et al. GM2 ganglioside as a regulator of pyramidal neuron dendritogenesis. 1998 Ann. N. Y. Acad. Sci. pmid:9668352
Kotagal S Diagnosis of AB variant, GM2 gangliosidosis. 1986 Ann. Neurol. pmid:3080943
Santafé MM et al. Changes in the neuromuscular synapse induced by an antibody against gangliosides. 2005 Ann. Neurol. pmid:15732093
Meek D et al. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis. 1984 Ann. Neurol. pmid:6430210
Navon R et al. Juvenile-onset spinal muscular atrophy caused by compound heterozygosity for mutations in the HEXA gene. 1997 Ann. Neurol. pmid:9153525
Renshaw PF et al. Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis. 1992 Ann. Neurol. pmid:1386210
Saito M and Sugiyama K Gangliosides in rat kidney: composition, distribution, and developmental changes. 2001 Arch. Biochem. Biophys. pmid:11360994
Ruan S et al. Analysis of melanoma cells stably transfected with beta 1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression. 1995 Arch. Biochem. Biophys. pmid:7487055
Jolivet-Reynaud C et al. Damaging effects of Clostridium perfringens delta toxin on blood platelets and their relevance to ganglioside GM2. 1988 Arch. Biochem. Biophys. pmid:3162668
Torres BV et al. Glycolipid-lectin interactions: reactivity of lectins from Helix pomatia, Wisteria floribunda, and Dolichos biflorus with glycolipids containing N-acetylgalactosamine. 1988 Arch. Biochem. Biophys. pmid:3355161
Duan J et al. Ganglioside GM2 modulates the erythrocyte Ca2+-ATPase through its binding to the calmodulin-binding domain and its 'receptor'. 2006 Arch. Biochem. Biophys. pmid:16962990
Hadfield MG et al. Pathologic findings in mucopolysaccharidosis type IIIB (Sanfilippo's sydnrome B). 1980 Arch. Neurol. pmid:6775621
Rapin I et al. Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship. 1976 Arch. Neurol. pmid:175770
Rockwell HE et al. AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system. ASN Neuro pmid:25873306
Kirvan CA et al. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. 2006 Autoimmunity pmid:16455579
Kasai N et al. Preparation and specificity of avian anti-GM2(NeuGc) ganglioside antiserum. 1985 Biochem. Biophys. Res. Commun. pmid:3925943
Li YT et al. Occurrence of ceramide-glycanase in the earthworm, Lumbricus terrestris. 1987 Biochem. Biophys. Res. Commun. pmid:3689409
Li SC et al. A new variant of type-AB GM2-gangliosidosis. 1981 Biochem. Biophys. Res. Commun. pmid:7306091
Nakamura M et al. Biosynthesis of the so-called "a" and "asialo" pathway glycosphingolipids is differentially regulated in murine myelogenous leukemia NFS60 cells. 1995 Biochem. Biophys. Res. Commun. pmid:8554592
Kuroki Y et al. A novel missense mutation (C522Y) is present in the beta-hexosaminidase beta-subunit gene of a Japanese patient with infantile Sandhoff disease. 1995 Biochem. Biophys. Res. Commun. pmid:7626071
Beccari T et al. GM2 activator protein expression in mouse tissues. 1994 Biochem. Biophys. Res. Commun. pmid:7980537
Tomioka R et al. Neuroblastoma GOTO cells are hypersensitive to disruption of lipid rafts. 2009 Biochem. Biophys. Res. Commun. pmid:19706290
Xie B et al. Isolation and expression of a full-length cDNA encoding the human GM2 activator protein. 1991 Biochem. Biophys. Res. Commun. pmid:2059210
Tanabe A et al. Obesity causes a shift in metabolic flow of gangliosides in adipose tissues. 2009 Biochem. Biophys. Res. Commun. pmid:19116132
Kondo Y et al. Glycosphingolipids are not pivotal receptors for Subtilase cytotoxin in vivo: sensitivity analysis with glycosylation-defective mutant mice. 2009 Biochem. Biophys. Res. Commun. pmid:18996356
Tanaka A et al. GM2-gangliosidosis B1 variant: a wide geographic and ethnic distribution of the specific beta-hexosaminidase alpha chain mutation originally identified in a Puerto Rican patient. 1988 Biochem. Biophys. Res. Commun. pmid:2973311
Hechtman P and Kachra Z Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside. 1980 Biochem. J. pmid:7387624
Hechtman P and LeBlanc D Purification and properties of the hexosaminidase A-activating protein from human liver. 1977 Biochem. J. pmid:603630
Masson E et al. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. 2005 Biochem. J. pmid:15654767
Haraguchi M et al. The effects of the site-directed removal of N-glycosylation sites from beta-1,4-N-acetylgalactosaminyltransferase on its function. 1995 Biochem. J. pmid:7492324
Li SC et al. Degradation of G(M1) and G(M2) by mammalian sialidases. 2001 Biochem. J. pmid:11696012
Hidari JK et al. beta 1-4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: isolation and characterization of a beta 1-4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma cell line AH7974F. 1994 Biochem. J. pmid:7980468
Bellachioma G et al. Cloning and sequence analysis of a cDNA clone coding for the mouse GM2 activator protein. 1993 Biochem. J. pmid:7689829
Klima H et al. Over-expression of a functionally active human GM2-activator protein in Escherichia coli. 1993 Biochem. J. pmid:8503891
Trinchera M et al. The N-acetylgalactosamine residue of exogenous GM2 ganglioside is recycled for glycoconjugate biosynthesis in rat liver. 1990 Biochem. J. pmid:2310367
DeGasperi R et al. Isolation and characterization of an activator protein for the hydrolysis of ganglioside GM2 from the roe of striped mullet (Mugil cephalus). 1989 Biochem. J. pmid:2527497
Kolter T et al. Recent advances in the biochemistry of glycosphingolipid metabolism. 1999 Biochem. Soc. Trans. pmid:10917612
Xie B et al. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A. 1998 Biochemistry pmid:9454570
Rigat B et al. Two mechanisms for the recapture of extracellular GM2 activator protein: evidence for a major secretory form of the protein. 1997 Biochemistry pmid:9204879
Tse R et al. Identification of functional domains within the alpha and beta subunits of beta-hexosaminidase A through the expression of alpha-beta fusion proteins. 1996 Biochemistry pmid:8718882
Tse R et al. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase. 1996 Biochemistry pmid:8652542
Hou Y et al. Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A. 1996 Biochemistry pmid:8672428
Martinez Z et al. GM1 specifically interacts with alpha-synuclein and inhibits fibrillation. 2007 Biochemistry pmid:17253773
Raghavan S et al. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis. 1985 Biochim. Biophys. Acta pmid:3995063
Hoffman LM et al. Human fetal brain cells in culture. Increase in GM2 ganglioside after SV-40 transformation. 1981 Biochim. Biophys. Acta pmid:6271225
Suzuki Y et al. Action of ortho- and paramyxovirus neuraminidase on gangliosides. Hydrolysis of ganglioside GM1 by Sendai virus neuraminidase. 1980 Biochim. Biophys. Acta pmid:6257300
Mahuran DJ Biochemical consequences of mutations causing the GM2 gangliosidoses. 1999 Biochim. Biophys. Acta pmid:10571007
Mahuran DJ The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein. 1998 Biochim. Biophys. Acta pmid:9714704
Sato T et al. Quantitative measurements of the interaction between monosialoganglioside monolayers and wheat germ agglutinin (WGA) by a quartz-crystal microbalance. 1998 Biochim. Biophys. Acta pmid:9545544
Rosales Fritz VM et al. Chinese hamster ovary cells lacking GM1 and GD1a synthesize gangliosides upon transfection with human GM2 synthase. 1997 Biochim. Biophys. Acta pmid:9396632
Suzuki KGN et al. Development of new ganglioside probes and unraveling of raft domain structure by single-molecule imaging. 2017 Biochim. Biophys. Acta pmid:28734966
Sanai Y et al. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc). 1988 Biochim. Biophys. Acta pmid:2449247
Taga S et al. Sequential changes in glycolipid expression during human B cell differentiation: enzymatic bases. 1995 Biochim. Biophys. Acta pmid:7811747
Chien JL and Hogan EL Characterization of two gangliosides of the paragloboside series from chicken skeletal muscle. 1980 Biochim. Biophys. Acta pmid:7236652
Hoffman LM et al. SV-40 transformation: effect on GM2 ganglioside in cultured cell lines. 1991 Biochim. Biophys. Acta pmid:1647206
Mahuran DJ The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis. 1991 Biochim. Biophys. Acta pmid:1825792
Karlsson G et al. Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2. 1990 Biochim. Biophys. Acta pmid:1691018
Yamanaka T et al. Detection of gangliotriaose-series glycosphingolipids in serum of cord blood and patients with neuroblastoma by a sensitive TLC/enzyme-immunostaining method. 1987 Biochim. Biophys. Acta pmid:3300782
Yanagisawa K et al. Purification and properties of GM2 synthase, UDP-N-acetylgalactosamine: GM3 beta-N-acetylgalactosaminyltransferase from rat liver. 1987 Biochim. Biophys. Acta pmid:3109491